ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 25 filers reported holding ATYR PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22 | -99.9% | 13,662 | +6.4% | 0.00% | -33.3% |
| Q2 2022 | $36,000 | -48.6% | 12,845 | -2.1% | 0.00% | -40.0% |
| Q1 2022 | $70,000 | -94.6% | 13,126 | -90.9% | 0.01% | -95.7% |
| Q3 2021 | $1,305,000 | +1108.3% | 143,677 | +418.0% | 0.12% | +858.3% |
| Q4 2020 | $108,000 | +129.8% | 27,736 | +148.0% | 0.01% | +140.0% |
| Q4 2019 | $47,000 | – | 11,183 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 1,225,833 | $9,157,000 | 2.55% |
| Stonepine Capital Management, LLC | 525,531 | $3,926,000 | 1.80% |
| Telemetry Investments, L.L.C. | 176,782 | $1,321,000 | 1.70% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $8,317,000 | 1.67% |
| VR Adviser, LLC | 1,565,000 | $11,691,000 | 1.60% |
| Deep Track Capital, LP | 1,100,000 | $8,217,000 | 0.58% |
| EAM Investors, LLC | 252,280 | $1,885,000 | 0.31% |
| EAM Global Investors LLC | 152,792 | $1,141,000 | 0.20% |
| FEDERATED HERMES, INC. | 5,222,250 | $39,010,000 | 0.07% |
| Alyeska Investment Group, L.P. | 674,975 | $5,042,000 | 0.06% |